FUNDING
Coverage Timeline
newest first- Aug 27, 2026FUNDINGTown Nears $1B Valuation in Index-Led Round~$1B valuation→
- Aug 27, 2026FUNDINGInstinct Hits $2.5B Valuation on $350M Raised$250M Series B at $2.5B→
- Aug 26, 2026FUNDINGInstinct's Valuation Rockets to $2.5B in Weeks$250M Series B→
- Jul 23, 2026FUNDINGFomo Raises $75M Series B for Consumer Crypto Trading$75M Series B→
- Jul 17, 2026FUNDINGChai Discovery Raises $400M at $3.8B for AI Drug Design$400M at $3.8B→
All Coverage
FUNDING~$1B valuation
Town Nears $1B Valuation in Index-Led Round
Enterprise AI assistant Town is raising at roughly a $1 billion valuation in a round led by Index Ventures, the second personal-assistant startup to reach a billion-dollar mark in a week.
DEEP DIVE
FUNDING
Instinct Hits $2.5B Valuation on $350M Raised
FUNDING$250M Series B at $2.5B
Instinct Hits $2.5B Valuation on $350M Raised
Instinct, the personal AI assistant built by 23-year-old founder Noah Shinn, has raised $350 million in total including a $250 million Series B co-led by Index Ventures and Benchmark at a $2.5 billion valuation.
DEEP DIVE
FUNDING
Instinct's Valuation Rockets to $2.5B in Weeks
FUNDING$250M Series B
Instinct's Valuation Rockets to $2.5B in Weeks
Instinct, a four-month-old AI assistant startup led by 23-year-old Noah Shinn, raised $250 million at a $2.5 billion valuation co-led by Index Ventures and Benchmark, up fivefold from $500 million just weeks earlier.
DEEP DIVE
FUNDING
Fomo Raises $75M Series B for Consumer Crypto Trading
FUNDING$75M Series B
Fomo Raises $75M Series B for Consumer Crypto Trading
Consumer crypto trading app Fomo raised a $75 million Series B led by Index Ventures at a $550 million valuation, adding equities and prediction markets after its first year saw $4 billion in trading volume.
FUNDING
Chai Discovery Raises $400M at $3.8B for AI Drug Design
FUNDING$400M at $3.8B
Chai Discovery Raises $400M at $3.8B for AI Drug Design
Life-sciences AI startup Chai Discovery raised a $400 million Series C at a $3.8 billion valuation led by Index Ventures, Sequoia, Dimension and Kleiner Perkins, one of the largest rounds yet for AI-driven drug and molecule design.